Research & Discovery
UConn Researchers Receive $1.7 Million Grant to Study Impact of Postinfectious Brain Condition on Development
This study will improve methods for investigating hydrocephalus progression, identify critical timepoints in neural development and highlight stem cells’ capacity for regenerative repair following infection.
UConn Researcher Hopes to Stop COVID-19 in Its Tracks
A UConn researcher is investigating a way to stop the COVID-19 virus from spreading through the body.
Using AI for Novel Thermoset Plastics
Ying Li has received a Young Investigator Award from the U.S. Air Force Office of Scientific Research to develop next gene thermoset plastics using artificial intelligence technology.
UConn Faculty Receive NIH Grant to Develop Smartphone Sensor to Detect Tooth Pain
UConn researchers are working to develop a smartphone app that can provide a quantitative assessment of toothache pain.
UConn Innovation Fund Invests in Two More University Startups
Two dynamic early-stage companies have been awarded early-stage funding from the $2.25 million UConn Innovation Fund.
UConn and Technion Collaborate on the Development of Next Generation Fuel Cells
UConn researchers and Technion, Israel Institute of Technology, are collaborating on a game-changing platinum-free fuel cell catalysts.
UConn Researchers Collaborate to Study Effects of COVID-19 on Domestic Violence
UConn researchers have won a grant to research the increase in domestic violence during the COVID-19 pandemic.
How Americans are Coping with COVID-19 Stress
UConn researchers are studying how Americans experience and respond to stress related to the COVID-19 pandemic.
Religion’s Influence on Child Success
An international research team including UConn's Richard Sosis received a grant from the John Templeton Foundation to examine the effects of religion on family dynamics, specifically family size and its relationship to child success.
Researchers Explore Potential Treatment for Mitochondrial Diseases
Researchers studying severe illnesses like muscular dystrophy and Parkinson's disease are intrigued by a group of compounds that may work to protect the body's cells.